Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 30

Results For "Development"

4214 News Found

Amgen appoints Madhur Sarin as Director – AI & Data Science COE
People | May 26, 2026

Amgen appoints Madhur Sarin as Director – AI & Data Science COE

Sarin will focus on advancing scalable AI-driven platforms and strengthening the company’s global data science capabilities across healthcare and enterprise technology domains


International Nurses Day 2026: WHO highlights global nursing gaps despite workforce growth
News | May 26, 2026

International Nurses Day 2026: WHO highlights global nursing gaps despite workforce growth

Fresh data from the State of the World’s Nursing 2025 report shows the global nursing workforce has expanded from 27.9 million in 2018 to 29.8 million in 2023


Genethon and Ampersand team up to engineer next-gen gene therapy vectors with precision
Biotech | May 26, 2026

Genethon and Ampersand team up to engineer next-gen gene therapy vectors with precision

AAV vectors are widely used in gene therapy for their strong therapeutic potential


Merck’s KEYTRUDA combo wins key EU backing for bladder cancer treatment
Drug Approval | May 25, 2026

Merck’s KEYTRUDA combo wins key EU backing for bladder cancer treatment

The decision now moves to the European Commission, with a final ruling expected by the third quarter of 2026


AbbVie scores key EU backing for Hepatitis C drug in push for earlier treatment
News | May 25, 2026

AbbVie scores key EU backing for Hepatitis C drug in push for earlier treatment

If cleared, MAVIRET would become one of the few therapies in the European Union approved to treat both acute and chronic hepatitis C infections


EMA accepts filing for Teva and Medincell’s long-acting schizophrenia treatment candidate
News | May 25, 2026

EMA accepts filing for Teva and Medincell’s long-acting schizophrenia treatment candidate

If approved, TEV-‘749 would mark a shift toward long-acting care aimed at improving treatment adherence in real-world settings


EU regulator backs Allergan Aesthetics’ Boey in key step toward approval
Drug Approval | May 25, 2026

EU regulator backs Allergan Aesthetics’ Boey in key step toward approval

The decision marks a key step in the centralized EU review process


Bristol Myers Squibb to unveil massive oncology data push at ASCO 2026
R&D | May 25, 2026

Bristol Myers Squibb to unveil massive oncology data push at ASCO 2026

The company said the breadth of its showcase reflects “progress from its differentiated oncology pipeline in solid tumors and hematologic malignancies,”


AstraZeneca to showcase cancer pipeline push at ASCO 2026
R&D | May 25, 2026

AstraZeneca to showcase cancer pipeline push at ASCO 2026

Across more than 85 abstracts, AstraZeneca will showcase 10 approved medicines and 13 potential new therapies


Merck doses first patient in Phase 3 trial of novel antibody-drug conjugate for metastatic colorectal cancer
Clinical Trials | May 23, 2026

Merck doses first patient in Phase 3 trial of novel antibody-drug conjugate for metastatic colorectal cancer

The trial will assess Precem-TcT, both as monotherapy and in combination with bevacizumab, in patients whose disease has progressed after or become resistant to standard treatments